02311nas a2200217   4500000000100000008004100001653003900042653002500081653001000106653002100116653003400137100001800171700001300189700001100202700001300213700001000226245013200236856008000368520163100448022001402079       2016                            d10aNeglected tropical diseases (NTDs)10aLymphatic filariasis10aIndia10aEconomic aspects10aCommunity based interventions1 aStillwaggon E1 aSawers L1 aRout J1 aAddiss D1 aFox L00aEconomic costs and benefits of a community-based lymphedema management program for lymphatic filariasis in Odisha State, India.  uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062793/pdf/tropmed-95-877.pdf3 a<p>Lymphatic filariasis afflicts 68 million people in 73 countries, including 17 million persons living with chronic lymphedema. The Global Program to Eliminate Lymphatic Filariasis aims to stop new infections and to provide care for persons already affected, but morbidity management programs have been initiated in only 24 endemic countries. We examine the economic costs and benefits of alleviating chronic lymphedema and its effects through a simple limb-care program. For Khurda District, Odisha State, India, we estimated lifetime medical costs and earnings losses due to chronic lymphedema and acute dermatolymphangioadenitis (ADLA) with and without a community-based limb-care program. The program would reduce economic costs of lymphedema and ADLA over 60 years by 55%. Savings of US$1,648 for each affected person in the workforce are equivalent to 1,258 days of labor. Per-person savings are more than 130 times the per-person cost of the program. Chronic lymphedema and ADLA impose a substantial physical and economic burden on the population in filariasis-endemic areas. Low-cost programs for lymphedema management based on limb washing and topical medication for infection are effective in reducing the number of ADLA episodes and stopping progression of disabling and disfiguring lymphedema. With reduced disability, people are able to work longer hours, more days per year, and in more strenuous, higher-paying jobs, resulting in an important economic benefit to themselves, their families, and their communities. Mitigating the severity of lymphedema and ADLA also reduces out-of-pocket medical expense.</p>
  a1476-1645